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filled bubbles within a sponge like gelatin matrix. In vitro ultrasonic testing
revealed a reflected digital echo intensity comparable to that of air filled al-
bumin microbubbles. However, the n’ricrospongedigital ultrasound intensity
persisted considerably longer during ultrasound exposure; rrrbosponge in-
tensity half-life 200 see, albumin microbubble half-life 2 sec. In vivo testing
in 4 dogs revealed left heart and myocardial nricrosponge persistence half-
times of 200 to 300 sec compared to albumin microbubble half-times of 3-5
sec. Thus a newly developed rnicrosporrge echo-contrast agent produces
a bright contrast echo effect and appears to resist pressure and ultrasonic
collapse. Thia new agent shows a 100 fold greater myooardial and left heart
persistence. These microspongesconsiderably enhance myocardial perfu-
sion studies.
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We have demonstrated acoustically reflective Iipoaomes targetad success-
fully to fibrin-bearing structures by covalent coupling to polyclonal rabbit
lgG antibodies that react equally with fibrinogen and fibrin (Am Diagnos-.
tics, #313R). Enhanced aoouetic imaging was demonstrated in vitro and
in vivo using a miniswine model of induced atherosclerosis. To determine
the effective antibody affinity requirkxi for successful Iiposome targeting, the
ability of the antibody preparation to increasing bind 1’= fibrinogen in the
preeenoa of increasing quantities of unlabeled fibrinogen (double-antibody
radioimmunoaasx+yprotocol) was assessed at three temperatures (4, 24 and
37QC).
Ffesuks:Two major orders of binding affinity were found: high (Id M-l)
and low (6 x 10% x 107 M-’). Higher affinity antibodies showad moderate
negative enthalpy and high positive entropy, indicating hydrophobic interac-
tions whereas lower affinity antibodies showed high negative enthalpy and
moderate negative entropy, indicating ionic interactions.
Conclusions:Our results suggest that acoustically reflective Iiposomes
can be targetad for site specific imaging using low-affinity antibodies with
major implications for their use for multistructure targeting, acoustic en-
hancement and drug delivery.
~ .afetyandEffi.acy OfAFOISOforCardiac
Contraat Enhancement in Normal Subjects:
Initiel Reeults of a Phase I Clinical Trial
B. Cotter, S. Mulvagh O.L. Kwan, S. Batra2, P.Manspeaker2,
T.J. Pelura2, P.T.Leese2, A.N. DeMaria. Universityof CaliforniaatS8n
Diego,MayoClinic,USA,2UniversifyofCaliforniaat SanDiago,Allisnce
PharrnsceuticalCorp.,USA
AFO150(lmagen@ US,Alliance Pharmaceutical Corp.) isanewpsrfluorohexane-
stabilized uitraaound oontraet agent that have demonstrated to produce in-
tense LV cavity and myocardial opacification following IV injections in ani-
mals. To determine the clinical safety and efficacy of this agent, a Phase I
study was undertaken in 64 healthy volunteera. 20subjscta received placebo
and 44 received incremental doses of AF0150 (0.125, 0.50, 2.0 and 4.0
m~kg. Cardiac imaging was obtainad with commercial instruments at 3.5
MHz in the paraatemal short axis or apical views. Safety assessments in-
cluded BP, HR, ECG, ventilator status, O#3at., CBC, chemistries, coagula-
tionand urine analysis. Alleubjacts tolerated all the injeotionswithout adverse
events and no clinically significant changes in the parameters obtainad were
observed. Echo revealed, at every dose, dense and total opacifioation of the
LV cavity following transient cavity and myocardial shadowing. Myocardial
opacifioation was visible in non-shadowed segments after all injections in
each subject. Vidaodeneitometry, 4 mm radius ROI positioned in the mid
wall of non-shadowed segments revealad an increase from baseline of 21 to
66, 40 and 49 gray levels at the incremental doses of 0.125, 0.50 and 2.0
m@g, reW@OfivelY.Thus AFO150produces dense LVcavity and myooardial
opaoifioation in normal subjects without significant adverse effects or clinical
or Iaboratoty abnormalities. This agent should prove useful for the clinical
assessment of myooardial perfusion.
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Influence of Ultrasonic Energy on Contrast
Echocardiography: Intermittent Imaging Using
AF0150 Yielda Generalized Mvocardial
Opaclfication While Continuok Imaging
Delineatea Intramyocardial Veasela
B. Cotter, K. Ohmori, A. Duong, O.L. Kwan, A.N. DeMaria. Universityof
Californiaat SanDiego,USA
AFO150(Imagent”, Alliance) is an intravenous contrast agent that has bean
fQUnd to produca linear or punctate signals compatible with intramyocardial
vessels rather than a diffuse myocardial blush during second harmonic (2H)
imaging. We have demonetratad that bubble destruction by amustic energy
was increased during low velocity flow. We hypothesized that continuous
(CONT) insonification destroyad bubbles in the low velocity microcircula-
tion but not in higher velocity vessels, and that this phenomenon muid be
reversed by intermittent imaging. Therefore, we mmpared CONT with ECG-
gatad imaging in 8 dogs given 1.5 mL of AFO150 IV. Shorl axis echo at the
mid-papillary level wae performed using different instruments capable of 2nd
H imaging bytransmiffing from 1.8 to2.5 MHzand receiving between 3.6and
5.0 MHz. Pulsed Doppler recordingsware obtainad from the Iinearstructures.
Off line videodensitometry (4 mm2 ROI, O-255 gray levels) was done on the
linear structures and adjacent myocardium. CONT imaging produced linear
or punotate structures compatible with intramyocardial vessels with a mean
inteneity of 96.8 + 55 gray levels (mean + SD), while myocardial intensity
was the same as baseline: 30.8 + 17 GL. Pulsed Doppler reoordinge from
these linear structures yieided predominantly diastolic velocities compatible
with coronary flow. ECG-gated imaging yielded a diffuse myocardial blush
with a mean peak videointensily of 93.4 + 35 GL throughout the wall. Thus,
during 2H imaging of AF0150, mntinuous insonification visualizes intramy-
ocardial vessels while intermittent imaging yields a generalized myocardial
blush. These data suRpoti the concept that lower velocity bubbles in the
microoiroulation are destroyed by acoustic anergy to a greater extent than
those in vessels. This differential response maybe of clinical value.
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We developed a non-recirculating, pressurized in vitro flow model in which
infused contrast echo bubbles flow through a gelatin matrix at a conatant
flow rate. Ultrasound imaging was petiormed with an HP SONOS 26CQ
prototype allowing us to control and to equalize pulses par burst and power
output for standard and harmonic imaging. For continuous or intermittent
gatedexposure, measurements byon-line Acouatic Denaitomet~ and bubble
counts uaing an optical Acusizer’” m770A system were obtained at inlet and
outlet. Three agents were studied: MRX115 (Aerosomes, lmaR); SonoGan
(QW7437, Sonus Pharrn.); and Imagent (AFO 150) (Alliance Pharrn.). MRX
showad a relative threshold for bubble destruction which increased above
a transmit gain of 40 (5.1 wattslcmz spatial peak pulse average). At levels
above this, even gated single burat imaging muld destroy all bubbles already
present within the imaging field (Fig.).
The Alliance agent showed similar characteristics with a destruction
threshold between 1 and 5 watta/cm2. There was no difference between
standard and harmonic imaging rasults for either agent once pulse ~wer
output and pulsas par burst were equalized. The Sonus agent, which mn-
tinuad to generate bubbles in our model at 3P, showed mote variability, but
once stabilized, its sensitivity to ultrasound power paralleled results for the
other agents. Our unique model combines controlled ultrasound power and
exposure as well as optical particle counting to provide insights about the
interaction between ultrasound imaging and bubble persistence.
